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Abstract
The International Commission on Radiological Protection (ICRP) states that particular 
attention should be paid to radiation effects on the cardiovascular system because of 
recent published observations of their effects occurring at lower doses than previously 
reported (ICRP, 2007 and 2012). The review was based on scientific articles available 
in open literature and major reviews by organizations, in particular ICRP118. In this 
review, we describe the low-dose ionizing radiation effects, the causes of cardiovascular 
diseases (CVDs), the relationship between low-dose ionizing radiation and CVDs, and 
the importance of elucidating the relationship between low-dose ionizing radiation and 
CVD.
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The International Commission on Radiological Protection 
(ICRP) states that particular attention should be paid to ra-
diation effects in the cardiovascular system because of recent 
published observations of their effects occurring at lower 
doses than previously reported (ICRP, 2007 and 2012). Our 
experimental study showed that repeated low-dose radiations 
promote abdominal aortic atherosclerosis in mice (unpub-
lished data). Based on these informations, the relationship 
between low-dose radiation exposure and cardiovascular dis-
eases (CVDs) was investigated in this review.
Low-Dose Ionizing Radiation Effect
Low-level radiations include low-dose and low-dose-rate-
ionizing radiations, low linear-energy-transfer (LET) radia-
tion (dose less than 0.2 Gy) or high LET radiation (dose less 
than 0.05 Gy), and dose rate less than 0.05/Gy/min. Studies 
on low-dose radiation remain inconclusive. Two opposing 
points of view are present in low-dose radiation: radiation 
hormesis and linear non-threshold (LNT) theory. In 1991, 
the US Department of Energy reported that workers with 
lifetime work doses of > 5 mSv had 24% lower full-fatality 
rates than non-nuclear workers, thereby confirming radiation 
hormesis. In 2006, an epidemiological study of high-back-
ground-radiation areas in Yangjiang (China) showed that 
adaptive responses, such as DNA repair, waste removal, 
apoptosis, and immune responses, occurred when the under-
lying level of damage expanded or spread to biological tissues 
[1]. Current radiation protection regulatory limits are based 
on the LNT theory using health data from atomic bomb sur-
vivors. Studies in recent years have sparked debate about the 
validity of the theory, especially at low doses [2]. The LNT 
model was recommended by the ICRP from a radiation pro-
tection point of view. This model states that the probabilities 
of inducing cancer and hereditary effects increase with dose 
linearly. Consequently, radiation exposure must be reason-
able and have adequate protections standard in place to keep 
the exposure below dose limits. The LNT model shows sat-
isfactory evidence at high doses; however for low doses, a 
linear fashion has less scientific evidence. Applications of the 
LNT model and radiation hormesis have an important effect 
on radiation protection and general human health [3].
Causes of Cardiovascular Diseases
CVD is the leading cause of death and disability in elderly 
people. Major modifiable risk factors for CVD include smok-
ing, physical inactivity, hypertension, hyperlipidemia, diabe-
tes, and obesity. Constitutional non-modifiable risk factors 
are age, gender, ethnicity, and family history. The Canadian 
Heart Health Survey in 1999 has revealed that smoking and 
stress are the main causes of heart disease, accounting for 
the largest proportion of patients (41% and 44%, respec-
tively), whereas hypertension accounted for only 16% [4]. 
According to the exposure distribution estimated by the 
China Health and Nutrition Survey in 2009, the population 
attributable risk for CVD events was 47.3% for hypertension, 
23.2% for physical inactivity, 18.5% for smoking, 13.5% for 
high BMI, 13.0% for high LDL cholesterol, 11.8% for hyper-
glycemia, 11.1% for low intake of fruits and vegetables, 7.1% 
for high sodium intake, and 3.5% for low polyunsaturated 
fatty acid intake; moreover, these values for the 2002 sur-
vey were 78.0%, 18.8%, 20.9%, 21.9%, 8.2%, 16.1%, 12.0%, 
20.3%, and 2.0%, respectively [5]. Most studies on adults and 
elderly showed that aging increases the chance of obtaining 
CVD. Age is the most common non-modifiable risk factor, 
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and diabetes, hyperlipidemia, and hypertension are highly 
common modifiable risk factors for CVD [6]. Moreover, race 
is a non-modifiable risk factor for CVD. According to the 
British Heart Foundation, different ethnic groups have their 
own culture and traditions [7]. A recent systematic review 
found the relative risk (RR) of early CVD. Family history can 
increase CVD events by more than 70%. In addition, family 
history of ischemic stroke can increase CVD risk in men by 
89% [8]. Other factors, such as diet, lifestyle, and metabolic 
risk factors for chronic diseases, also lead to high CVD mor-
bidity and mortality.
Relationship between Low-Dose Ionizing Radiation and 
Cardiovascular Diseases
In the United Nations Scientific Committee on the Effects of 
Atomic Radiation (UNSCEAR), cardiovascular data were re-
cently updated up to the end of 2000, and estimated relative 
risk (ERR) of ischemic heart disease was 0.41 Gy−1 [9].
Atomic Bomb Survivors
Low-dose radiation increases risk for CVD; this finding was 
first observed from non-cancer disease data of the Life Span 
Study (LSS), which investigated Japanese atomic bomb sur-
vivors that were exposed to radiation doses < 5 Gy [10, 11]. 
60 percent of non-cancer patients dying with circulatory dis-
ease [11].Most studies on low-dose radiation were associat-
ed with increased CVD, including heart disease, high blood 
pressure, rheumatic heart disease, and heart failure [11]. 
Moreover, a dose–response relationship was found in a study 
of 288 incident cases of myocardial infarction in the clinical 
(Adult Health Study) subset of the LSS cohort, and RR at 1 
Gy was estimated to be 1.17 (95% CI 1.01–1.36) [12].
Occupational Exposures
Mineral studies in Newfoundland and Canada have shown 
a correlation between coronary heart disease and radon ex-
posure [13, 14]. RR of coronary heart disease mortality in-
creased with cumulative radon exposure dose, but the trend 
test was borderline (P = 0.09). In a large cohort study of 
59,000 miners working in a uranium mine in Wismut (Ger-
many) from 1946 to 1989, 5,417 deaths from circulatory 
diseases (3,719 cases of heart disease, 1,297 cases of cerebro-
vascular disease) were followed up to the end of 1998 [14]. 
The pooled analysis involved approximately 42,000 employ-
ees with external and internal radiation exposures at British 
Nuclear Fuels plc; furthermore, a significant dose–response 
relationship was observed for mortality from circulatory dis-
ease (ERR/Sv = 0.65, 90% CI 0.36–0.98) and ischemic heart 
disease (ERR/Sv = 0.70, 90% CI 0.33–1.11) [15]. Notably, 
among US radiological technologists, early workers have in-
creased cardiovascular and cerebrovascular mortalities [16].
Medical Exposures
A dose–response relationship was observed between coro-
nary heart disease and radiation doses [17]. Increasing cardi-
ac morbidity and mortality and risk of CVDs have been wide-
ly found after radiation therapy (RT), especially beam RT, 
for breast cancer, lung cancer, esophageal cancer, and even 
peptic ulcer [18-21]. General risk factors for CVDs, such as 
hypertension, diabetes, hypercholesterolemia, obesity, and 
smoking, probably also increase the risk of CVDs in patients 
treated with radiotherapy indirectly; for example, irradiation 
of the left kidney during para-aortic and spleen radiothera-
py can result in hypertension [22-26]. The estimated ERR/
Gy of cardiovascular morbidity as a whole is 0.10 (95% CI 
0.07–0.13) and that of mortality is 0.08 (95% CI 0.04–0.12). 
Not all circulatory disease cases are lethal; however, they have 
a high corresponding percentage of morbidity. Based on the 
hypothesis, a radiation of approximately 0.5 Gy may induce 
circulatory disease at approximately 1% of the exposed pop-
ulation [11].
Molecular Mechanisms
The main mechanisms of low-dose radiation-induced cardiac 
damage are inflammatory processes [11]. Many inflammato-
ry markers (C-reactive protein, IL-6, and sialic acid) are in-
creased significantly at a dose-related fashion [27, 28]. The 
data of health examination showed radiation can induce cal-
cification of aortic arch, a rise in systolic and diastolic blood 
pressure [29] and serum cholesterol levels [30], and has dose 
effect relation to some extent[31]. Whole-body doses of rats 
from 0.1–0.6 Gy inhibited leukocyte adhesion to endothelial 
cells [32], and doses from 0.025–0.05 Gy manifested protec-
tive effects on the development of atherosclerosis in ApoE 
knockout mice, especially at low dose rates [33]. It suggested 
that an non-liner dose-response relationship existed between 
radiation and atherosclerosis, that is also to say a protective 
effect on cardiovascular in very-low-dose occupational expo-
sures (0.02 Sv), but detrimental effects in higher doses (0.2 
Sv) in epidemiological researches [34]. After low-dose ra-
diation, the earliest morphological changes in the irradiated 
heart were lymphocyte adhesion and extravasation, thereby 
causing changes in the function of capillary endothelial cells 
and leading to thrombosis, microvascular obstruction, and 
decreased capillary density, accompanied by loss of endothe-
lial cell markers of alkaline phosphatase [35-37]. Increased 
proliferation ability of the remaining capillary endothelial 
cells is not sufficient to maintain proper microvascular func-
tion and therefore led to ischemia, myocardial cell death, and 
fibrosis [38]. Radiation-induced genomic instability [39], 
monocyte killing, and increased levels of monocyte che-
mo-attractant protein 1 have been presumed to be associated 
with low-dose post-atherosclerosis initiation and progression 
[40].
CONCLUSIONS
From atomic bomb survivors, occupational exposures, med-
ical exposures, and accidental exposures, the relationship 
between low-dose radiation and CVDs was investigated, and 
the molecular mechanisms were summarized. Data from the 
LSS cohort of Japanese atomic bomb survivors indicated that 
the mortality rate of circulatory disease is high. The dose–ef-
fect threshold of heart disease is 0 Gy, signifying no thresh-
old. Patients exposed to 1–2 Gy radiotherapy had increased 
risks of CVD; however, this risk becomes notable 10–20 
years after exposure. The risk of CVD in accidental or occu-
pational total-body exposure is high; however, due to carious 
confounding factors, the correlation between radiation and 
CVD cannot be concluded. The dose–effect model below 0.5 
Gy is uncertain. The microvascular damage of myocardium 
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is main cause of Radiation-induced heart disease, generally 
lead to focal myocardial degeneration, fibrosis, and accelerat-
ed atherosclerosis in major blood vessels. Occupational and 
medical exposures account for the largest proportions in the 
low-dose population. Repeated radiological diagnostic exam-
inations induce significant radiation exposure and their use 
increase every year. On the other hand, in 2006, the per capi-
ta dose from medical exposure (not including dental imaging 
or radiotherapy) in the USA was approximately 0.003 Sv. The 
main radiation sources were computed tomography scans, 
angiography, and vascular interventions. The average lifetime 
dose was estimated to be 20 Sv in radiologists between 1897 
and 1920, 3.8 Sv between 1921 and 1935, 1.25 Sv between 
1936 and 1954, and 0.1 Sv between 1955 and 1979 [41-43]. 
Statins (usually used to treat heart disease) and glutamine 
supplementation have therapeutic effects; however, no re-
mission agents are known to slow radiation-induced CVD. 
Fortunately, ongoing laboratory studies are further exploring 
the efficacy of stem cell transplantation or stem cell products. 
Therefore, the relationship between low-dose ionizing radia-
tion and CVD needs to be elucidated.
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